1317 (1317) Fair Value & Analysis

Consumer Defensive · Market cap HK$471M

1 1317 1317 · HK

PriceHK$0.1670

Fair ValueHK$0.1499

Upside-10.2%

Quality53/100

Watch 1317 for free — get notified when fair value or trend changes. Watch for free

Evidence: High Range HK$0.0947 – HK$0.2421

Fair value as of: Jul 2, 2026

From 24 valuation models · updated yesterday

Share price −11.9% over the past month.

Price vs Fair Value (12 months)

12‑month range HK$0.1576 – HK$0.4670 · fair‑value band HK$0.0947 – HK$0.2421 · the HK$0.1670 price screens above the HK$0.1499 fair value. As of Jul 2, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

1317 (1317) currently trades at HK$0.1670, while our model-based Fair Value estimate is HK$0.1499 — implying the stock looks roughly 10.2% overvalued today. We read business quality at 53/100 (solid quality), in the Consumer Defensive sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: high).

Over the trailing twelve months, 1317 generated revenue of HK$1.1B at a net margin of 27.9%. Revenue declined 11.2% year over year. It earns a return on equity of 17.3%. Net debt stands at HK$777M. Fundamentals as of Jul 2, 2026

Key figures & financial health

Revenue (TTM) HK$1.1B

Revenue growth (YoY) -11.2%

Net margin 27.9%

Return on equity 17.3%

Free cash flow HK$330M FY2025

P/E ratio 1.4

More key figures

Operating margin 23.0%

EPS (TTM) HK$0.0700

EPS growth (YoY) +4.0%

Net debt HK$777M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 2, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

1317 reported revenue of HK$1.2B in FY2025 versus HK$941M in FY2021, a compound +5.5%/yr. Reported net income was HK$306M in FY2025.

Revenue +5.5%/yr

FY21 HK$941M

FY22 HK$990M

FY23 HK$1.2B

FY24 HK$1.2B

FY25 HK$1.2B

Net income

FY21 −HK$3.1B

FY22 HK$57.1M

FY23 HK$5.1M

FY24 HK$15.5M

FY25 HK$306M

Is 1317 fairly valued? → Check now

Similar stocks

6 more Education & Training Services stocks, each showing price versus our Fair Value estimate (as of Jul 2, 2026).

Stock	Price	Fair Value	vs Fair Value
New Oriental Education & Technology Group EDUN	966.48 MXN	895.77 MXN	-7%
9901 9901	HK$36.30	HK$4.84	-87%
TAL Education Group T1AL34	R$4.84	R$0.5800	-88%
Graham Holdings GHC	$1,147	$1,170	+2%
Laureate Education, Inc LAUR	$33.82	$33.05	-2%
Covista Inc CVSA	$119.28	$137.46	+15%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks Technology Financial Services Healthcare Consumer Cyclical Consumer Defensive Communication Services Industrials Energy Basic Materials Real Estate Utilities Deeply Undervalued Stocks Undervalued Blue-Chip Stocks Undervalued Small-Cap Stocks

Frequently asked questions

Is 1317 (1317) undervalued?

As of Jul 2, 2026, our model estimates a fair value of HK$0.1499 versus a price of HK$0.1670 — about −10% (overvalued). Model-based estimate, not financial advice.

What is the fair value of 1317?

Our model-based fair value for 1317 is HK$0.1499 (as of Jul 2, 2026), built from audited fundamentals. The current price is HK$0.1670.

What is the quality score of 1317?

1317 has a Quality Score of 53/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

What is the revenue of 1317 (1317)?

1317 reported trailing-twelve-month revenue of about HK$1.1B (latest available figure, as of Jul 2, 2026).

What is the net profit margin of 1317?

The net profit margin of 1317 is about 27.9%, meaning it keeps roughly 27.9% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.